Baidu
map

恶性胸膜间皮瘤诊疗共识(试行)

2017-11-20 浙江省抗癌协会肺癌专业委员会 胸壁(膜)、纵隔肿瘤学组 肿瘤学杂志.2017.

浙江省抗癌协会肺癌专业委员会胸壁(膜)、纵隔肿瘤学组发布的恶性胸膜间皮瘤诊疗共识(试行),主要内容包括:流行病学调查,影像学诊断,病理学诊断,分期,外科治疗,放射治疗,系统治疗和姑息治疗。

中文标题:

恶性胸膜间皮瘤诊疗共识(试行)

发布日期:

2017-11-20

简要介绍:

浙江省抗癌协会肺癌专业委员会胸壁(膜)、纵隔肿瘤学组发布的恶性胸膜间皮瘤诊疗共识(试行),主要内容包括:流行病学调查,影像学诊断,病理学诊断,分期,外科治疗,放射治疗,系统治疗和姑息治疗。

 

拓展指南:恶性胸膜间皮瘤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=恶性胸膜间皮瘤诊疗共识(试行))] GetToolGuiderByIdResponse(projectId=1, id=9e8f91c00152e3f0, title=恶性胸膜间皮瘤诊疗共识(试行), enTitle=, guiderFrom=肿瘤学杂志.2017., authorId=null, author=, summary=浙江省抗癌协会肺癌专业委员会胸壁(膜)、纵隔肿瘤学组发布的恶性胸膜间皮瘤诊疗共识(试行),主要内容包括:流行病学调查,影像学诊断,病理学诊断,分期,外科治疗,放射治疗,系统治疗和姑息治疗。 , cover=, journalId=null, articlesId=null, associationId=1553, associationName=浙江省抗癌协会肺癌专业委员会 胸壁(膜)、纵隔肿瘤学组, associationIntro=, copyright=0, guiderPublishedTime=Mon Nov 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>浙江省抗癌协会肺癌专业委员会胸壁(膜)、纵隔肿瘤学组发布的恶性胸膜间皮瘤诊疗共识(试行),主要内容包括:流行病学调查,影像学诊断,病理学诊断,分期,外科治疗,放射治疗,系统治疗和姑息治疗。 </P> <P> </P>拓展指南:<STRONG>与<FONT color=red>恶性胸膜间皮瘤</FONT>相关指南:</STRONG><BR> <UL> <LI><A title=NCCN临床实践指南:恶性胸膜间皮瘤(2017.V2) target=_blank href="//m.sandwebs.com/guideline/show_article.do?id=4d7e11c001a66908">NCCN临床实践指南:恶性胸膜间皮瘤(2017.V2)</A> <LI><A title=NCCN临床实践指南:恶性胸膜间皮瘤(2017.V1) target=_blank href="//m.sandwebs.com/guideline/show_article.do?id=dd5d71c0013905b2">NCCN临床实践指南:恶性胸膜间皮瘤(2017.V1)</A> <LI><A title="2016 NCCN临床实践指南:恶性胸膜间皮瘤-证据块(2016.V3)" target=_blank href="//m.sandwebs.com/guideline/show_article.do?id=d208c1c0012396f0">2016 NCCN临床实践指南:恶性胸膜间皮瘤-证据块(2016.V3)</A> <LI><A title="2016 NCCN临床实践指南:恶性胸膜间皮瘤(2016.V3)" target=_blank href="//m.sandwebs.com/guideline/show_article.do?id=3042b1c0012395a8">2016 NCCN临床实践指南:恶性胸膜间皮瘤(2016.V3)</A> <LI><A title="2015 ESMO临床实践指南:恶性胸膜间皮瘤的诊断,治疗和随访" target=_blank href="//m.sandwebs.com/guideline/show_article.do?id=62de51c00121ea94">2015 ESMO临床实践指南:恶性胸膜间皮瘤的诊断,治疗和随访</A> 更多信息请点击:<A target=_blank href="//m.sandwebs.com/guideline/list.do?q=%E6%81%B6%E6%80%A7%E8%83%B8%E8%86%9C%E9%97%B4%E7%9A%AE%E7%98%A4">有关恶性胸膜间皮瘤更多指南</A></LI></UL>, tagList=[TagDto(tagId=25597, tagName=恶性胸膜间皮瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5671, appHits=316, showAppHits=11, pcHits=3964, showPcHits=2065, likes=134, shares=15, comments=12, approvalStatus=1, publishedTime=Sun Dec 03 22:10:16 CST 2017, publishedTimeString=2017-11-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 03 22:10:16 CST 2017, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 23:03:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=恶性胸膜间皮瘤诊疗共识(试行))])
恶性胸膜间皮瘤诊疗共识(试行)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=279494, encodeId=42522e94943e, content=中文版有没有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/1iaEzwaAJCf7Jk0uMia0g5JhQmm3yN8yKyygGPQ9ichzSO3CkLaVMuV9jADpziaxssbRHfz4x03PTFNUb7icpxtrJNw/132, createdBy=e6892250590, createdName=李娟775885, createdTime=Wed Jan 17 20:31:51 CST 2018, time=2018-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267223, encodeId=6ee026e223db, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Wed Dec 06 10:18:28 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266658, encodeId=622826665804, content=大家形成共识.指导今后的规范工作, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6lQViaiaazgKwu3ASkx2y57ib6ISo2VFcU2BYlssBOpcOQcjB5rSVpl36mTeQD5lzAvY9wwxyOuebVA/0, createdBy=57c11919303, createdName=wl1122050, createdTime=Mon Dec 04 07:35:51 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2018-01-17 李娟775885

    中文版有没有

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=279494, encodeId=42522e94943e, content=中文版有没有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/1iaEzwaAJCf7Jk0uMia0g5JhQmm3yN8yKyygGPQ9ichzSO3CkLaVMuV9jADpziaxssbRHfz4x03PTFNUb7icpxtrJNw/132, createdBy=e6892250590, createdName=李娟775885, createdTime=Wed Jan 17 20:31:51 CST 2018, time=2018-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267223, encodeId=6ee026e223db, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Wed Dec 06 10:18:28 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266658, encodeId=622826665804, content=大家形成共识.指导今后的规范工作, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6lQViaiaazgKwu3ASkx2y57ib6ISo2VFcU2BYlssBOpcOQcjB5rSVpl36mTeQD5lzAvY9wwxyOuebVA/0, createdBy=57c11919303, createdName=wl1122050, createdTime=Mon Dec 04 07:35:51 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-06 xiaotao112411

    学习学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=279494, encodeId=42522e94943e, content=中文版有没有, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/1iaEzwaAJCf7Jk0uMia0g5JhQmm3yN8yKyygGPQ9ichzSO3CkLaVMuV9jADpziaxssbRHfz4x03PTFNUb7icpxtrJNw/132, createdBy=e6892250590, createdName=李娟775885, createdTime=Wed Jan 17 20:31:51 CST 2018, time=2018-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=267223, encodeId=6ee026e223db, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/05/dc628308c49d4aa82335673176ebb6d3.jpg, createdBy=153c1955083, createdName=xiaotao112411, createdTime=Wed Dec 06 10:18:28 CST 2017, time=2017-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266658, encodeId=622826665804, content=大家形成共识.指导今后的规范工作, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM6lQViaiaazgKwu3ASkx2y57ib6ISo2VFcU2BYlssBOpcOQcjB5rSVpl36mTeQD5lzAvY9wwxyOuebVA/0, createdBy=57c11919303, createdName=wl1122050, createdTime=Mon Dec 04 07:35:51 CST 2017, time=2017-12-04, status=1, ipAttribution=)]
    2017-12-04 wl1122050

    大家形成共识.指导今后的规范工作

    0

Baidu
map
Baidu
map
Baidu
map